Aspirin; pentazocine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for aspirin; pentazocine hydrochloride and what is the scope of freedom to operate?
Aspirin; pentazocine hydrochloride
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for aspirin; pentazocine hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | aspirin; pentazocine hydrochloride at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for aspirin; pentazocine hydrochloride
US Patents and Regulatory Information for aspirin; pentazocine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TALWIN COMPOUND | aspirin; pentazocine hydrochloride | TABLET;ORAL | 016891-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for aspirin; pentazocine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TALWIN COMPOUND | aspirin; pentazocine hydrochloride | TABLET;ORAL | 016891-001 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |